import data_1_a from '../../images/new_billion_scale.png';
import data_1_b from '../../images/Chip-e1518601899365-no5fx2j0hnpezo5l54hrjzg1usqhw6yt4b2055cpgo.png';
import data_1_video from '../../images/farmers.mp4';
import data_1_chip from '../../images/GSI_chip_clip.png';
import data_2_a from '../../images/PgIsmkx.jpg';
//import data_2_pipeline from '../../images/pipeline2.png'
import data_2_pipeline from '../../images/pipeline.png'
import data_2_molecules from '../../images/molecules.jpg'
import data_2_latency from '../../images/fastmol.png'
import data_2_leader from '../../images/leader.jpg'

export const DATA = [
  {
    "id": 1,
    "main_image": data_1_a,
    "product": {
      "title": "Edge AI Computing-Based",
      "sub_title": "Smart City Solutions",
      "description": "Empowering smart cities with AI capabilities has become an inevitable trend as technologies develop.With Horizon's proprietary edge AI computing and superior deep learning algorithms, AI computations can be achieved at edge in forms of video structuring industrial PCs or a full stack smart city solution that provides ultimate efficiency in both power consumption and cost while sustaining a high performance.",
    },
    "techincal": {
      "title": "Technical Advantages",
      "advantage": [
        {
          "img": data_1_a,
          "title": "High-performance",
          "description": "Deep learning based visual identification, and quick matching with the target library; Maximum resolution 2M（1920×1080@30fps）",
          "pg": "undefined"
        },
        {
          "img": data_1_a,
          "title": "Low-cost",
          "description": "Supports front-end database",
          "pg": "undefined"
        },
        {
          "img": data_1_a,
          "title": "Low power consumption",
          "description": "Equipped with Horizon's edge AI computing, providing deep learning algorithms-based features.",
          "pg": "undefined"
        },
        {
          "img": data_1_a,
          "title": "Multiple levels",
          "description": "Supporting 3D digital noise reduction, ultra-wide dynamic, automatic electronic shutter; supporting PoE power supply",
          "pg": "undefined"
        }
      ]
    },
    "middle": {
      "title": "Intelligent Traffic Platform",
      "content": [
        {
          "img": data_1_b,
          "title": "Traffic violation analysis",
          "description": "Through automatically detecting, capturing and obtaining evidence, it assists in analysis traffic violations such as running red lights, prohibited cornering and line crossing, going in the wrong direction and illegal parking.",
          "pg": "undefined"
        },
        {
          "img": data_1_b,
          "title": "Intelligence analysis",
          "description": "It enables tracking and behavior analysis of particular vehicle targets, detects illegal behaviors such as vehicles with counterfeit registration plates, and provides accompanying vehicle analysis, correlation analysis and general vehicle surveillance.",
          "pg": "undefined"
        },
        {
          "img": data_1_b,
          "title": "Road condition analysis",
          "description": "Based on the vehicle capture, it provides traffic congestion detection, traffic anomaly analysis, and traffic condition analysis.",
          "pg": "undefined"
        },
        {
          "img": data_1_b,
          "title": "Big data analysis",
          "description": "Based on the analysis of big data in traffic scenarios, it is able to predict road condition changes, analyze urban functional zones, and assist in urban traffic road planning.",
          "pg": "undefined"
        }
      ]
    },
    "video": {
      "title": "Video Structuring",
      "content": "Based on the deep learning technologies, it detects, captures, tracks, and identifies pedestrians and vehicles in every frame of the video, and converts non-structured video data to structured analytical data of different types of road users.",
      "image": data_1_a,
      "url": data_1_video
    }
  },
  {
    "id": 2,
    "main_image": data_2_a,
    "product": {
      "title": "Computational Drug Discovery",
      "sub_title": "Small Molecule Search",
      "description": "\"By dramatically reducing the time required to search our small-molecule database, GSI’s Gemini empowers us to advance our research processes and ultimately improve human health.\" \n --Efrat Ben-Zeev, Computational Chemist and Cheminformatics Project Leader Weizmann Institute of Science.",
    },
    "techincal": {
      "title": "The GSI Advantage",
      "advantage": [
        {
          "img": data_2_latency,
          "title": "Lowers Drug Development Time and Cost",
          "description": "Virtual screening is one of the keys to lowering development costs and time. Gemini optimizes virtual screening by providing fast similarity search. Searches that used to take minutes now only take a few hundred milliseconds - greatly improving researchers’ ability to explore the chemical space in depth.",
          "pg": "undefined"
        },
        {
          "img": data_2_molecules,
          "title": "Provides Scalability",
          "description": "Gemini’s ultra-fast similarity search eliminates the need to index a small-molecule database. This simplifies database management, and makes it easy to add compounds to the database and to scale the database.",
          "pg": "undefined"
        },
        {
          "img": data_2_pipeline,
          "title": "Allows for Flexible Searches",
          "description": "Gemini provides the flexibility to work with many different types of molecule fingerprints such as MDL, ECFP, and FCFP, and can work with longer fingerprints (e.g., 8192-bit fingerprints). Gemini also allows for flexible similarity search thresholds to be set. For example, one could initially set the threshold to below 0.4 to find diverse set of molecules to explore. This greatly improves the chances of discovering novel compounds. Then with a diverse set of molecules now in hand, one could set a higher threshold of around 0.8 to find very similar molecules to the hits and to expand the hit space.",
          "pg": "undefined"
        },
        {
          "img": data_2_leader,
          "title": "Industry Leader",
          "description": "Our similarity search hardware accelerator is being used by the biggest names in biopharma including the Weizmann Institute.",
          "pg": "undefined"
        }
      ]
    },
    "middle": {
      "title": "Molecule Search In Milliseconds",
      "content": [
        {
          "img": data_1_b,
          "title": "Resources",
          "description": "Get more production information about Gemini.",
          "pg": "undefined"
        },
        {
          "img": data_1_b,
          "title": "Customer Stories",
          "description": "See how customers are using Gemini now.",
          "pg": "undefined"
        },
        {
          "img": data_1_b,
          "title": "Blog",
          "description": "Read more about our approach to drug discovery.",
          "pg": "undefined"
        },
        {
          "img": data_1_b,
          "title": "Events",
          "description": "Join us at an upcoming meetup or conference.",
          "pg": "undefined"
        }
      ]
    },
    "video": {
      "title": "Challenges",
      "content": "Drug discovery is a big business. According to Research and Markets, the global small molecule drug discovery market was about $29B in 2018 and is predicted to be roughly $47B in 2024. It is, however, also a difficult business. The average cost to develop a new drug is roughly $2.6 billion, and 90% of new drugs fail to win approval. For those few that do manage to win approval, it still takes at least 10 years to get them to market. So it’s no surprise that leading pharmaceutical companies are always under pressure to find ways to lower the cost and time needed to discover new drugs.",
      "image": data_1_a,
      "url": data_1_video
    },
    "solution": {
      "title": "Our Solution",
      "content":"Our approach to this problem is based on hardware acceleration. Gemini is a custom, compute-in-memory chip that combines high speed SRAM and programmable bit-logic interleaved throughout the memory. Gemini computes functions directly on the data using parallel processing. Gemini can be used for ultra-fast molecular structural similarity/substructure search to advance powerful existing structural similarity search algorithms in drug discovery.",
      "image": data_1_chip,
      "url": data_1_video 
    },
    "challenge": {
      "title": "Challenges",
      "content": "Drug discovery is a big business. According to Research and Markets, the global small molecule drug discovery market was about $29B in 2018 and is predicted to be roughly $47B in 2024. It is, however, also a difficult business. The average cost to develop a new drug is roughly $2.6 billion, and 90% of new drugs fail to win approval. For those few that do manage to win approval, it still takes at least 10 years to get them to market. So it’s no surprise that leading pharmaceutical companies are always under pressure to find ways to lower the cost and time needed to discover new drugs.",
      "image": data_1_a,
      "url": data_1_video 
    },
    "questions": {
      "route": "/question",
      "title": "To see if our solution is right for you, ",
      "title_link": "contact us."
    }
  }
]
